Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces

Journal of Biological Chemistry

Volumn 286, Issue 1, 2011, Pages 123-130

  Pham, Christine T N ^a,c   Mitchell, Lynne M ^a   Huang, Jennifer L ^a   Lubniewski, Christopher M ^a   Schall, Otto F ^b   Killgore, J Kendall ^b   Pan, Dipanjan ^a   Wickline, Samuel A ^a   Lanza, Gregory M ^a   Hourcade, Dennis E ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Kereos Inc   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL STRUCTURE; CLASSICAL PATHWAY; COMPLEMENT ACTIVATIONS; COMPLEMENT SYSTEMS; ENCAPSULATED NANOPARTICLES; FUNCTIONALIZED; HUMAN DISEASE; IN-VITRO ASSAYS; IN-VIVO; INNATE IMMUNE RESPONSE; INNATE IMMUNITY; MOUSE MODELS; NANO-MATERIALS; NANOPARTICLE SURFACE; POTENTIAL EFFECTS; QUANTITATIVE APPROACH; REGULATORY PROTEIN; STRUCTURE ACTIVITY RELATIONSHIPS; SURFACE FUNCTIONALIZATION;

ANTIBODIES; BIOLOGICAL MATERIALS; CHELATION; GADOLINIUM; LIPOSOMES; NANOPARTICLES; NANOSTRUCTURED MATERIALS; PHOSPHOLIPIDS; STRUCTURE (COMPOSITION); ZETA POTENTIAL;

SURFACES;

GADOLINIUM; IMMUNOGLOBULIN M ANTIBODY; NANOPARTICLE; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SURFACE PROPERTY; ZETA POTENTIAL;

ANIMALS; ANTIBODIES; COMPLEMENT SYSTEM PROTEINS; DRUG DESIGN; GADOLINIUM; HUMANS; IMMUNOGLOBULIN M; MICE; NANOCAPSULES; PHOSPHOLIPIDS; SURFACE PROPERTIES;

EID: 78650943096     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M110.180760     Document Type: Article

References (37)

1. Petros, R. A., and DeSimone, J. M. (2010) Nat. Rev. Drug Discov. 9, 615-627
2. Fischer, H. C., and Chan, W. C. (2007) Curr. Opin. Biotechnol. 18, 565-571
3. Dobrovolskaia, M. A., and McNeil, S. E. (2007) Nat. Nanotechnol. 2, 469-478
4. Szebeni, J. (2005) Toxicology 216, 106-121
5. Nilsson, B., Korsgren, O., Lambris, J. D., and Ekdahl, K. N. (2010) Trends Immunol. 31, 32-38
6. Szebeni, J., Fontana, J. L., Wassef, N. M., Mongan, P. D., Morse, D. S., Dobbins, D. E., Stahl, G. L., Bünger, R., and Alving, C. R. (1999) Circulation 99, 2302-2309
7. Walport, M. J. (2001) N. Engl. J. Med. 344, 1058-1066
8. Walport, M. J. (2001) N. Engl. J. Med. 344, 1140-1144
9. Ricklin, D., Hajishengallis, G., Yang, K., and Lambris, J. D. (2010) Nat. Immunol. 11, 785-797
10. Wright, S. D., and Silverstein, S. C. (1983) J. Exp. Med. 158, 2016-2023
11. Klos, A., Tenner, A. J., Johswich, K. O., Ager, R. R., Reis, E. S., and Köhl, J. (2009) Mol. Immunol. 46, 2753-2766
12. Liszewski, M. K., and Atkinson, J. P. (1998) in The Human Complement System in Health and Disease (Volanakis, J. E., and Frank, J. A., eds) pp. 149-166, Marcel Dekker, Inc, New York
13. Till, G. O., Johnson, K. J., Kunkel, R., and Ward, P. A. (1982) J. Clin. Invest. 69, 1126-1135
14. Till, G. O., and Ward, P. A. (1986) Fed. Proc. 45, 13-18
15. Tvedten, H. W., Till, G. O., and Ward, P. A. (1985) Am. J. Pathol. 119, 92-100
16. Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C., Jr., Carson, G. R., Concino, M. F., Boyle, M. P., Roux, K. H., Weisfeldt, M. L., and Fearon, D. T. (1990) Science 249, 146-151
17. Lanza, G. M., Wallace, K. D., Scott, M. J., Cacheris, W. P., Abendschein, D. R., Christy, D. H., Sharkey, A. M., Miller, J. G., Gaffney, P. J., and Wickline, S. A. (1996) Circulation 94, 3334-3340
18. Caruthers, S. D., Wickline, S. A., and Lanza, G. M. (2007) Curr. Opin. Biotechnol. 18, 26-30
19. Sadeghi, M. M., Krassilnikova, S., Zhang, J., Gharaei, A. A., Fassaei, H. R., Esmailzadeh, L., Kooshkabadi, A., Edwards, S., Yalamanchili, P., Harris, T. D., Sinusas, A. J., Zaret, B. L., and Bender, J. R. (2004) Circulation 110, 84-90
20. Whaley, K., ed (1985) in Methods in Complement for Clinical Immunologists, pp. 77-139, Churchill Livingstone, New York
21. Atkinson, J. P., McGinnis, K., and Shreffler, D. (1980) J. Immunol. Methods 33, 351-368
22. Botto, M., Dell'Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., and Walport, M. J. (1998) Nat. Genet. 19, 56-59
23. Fischer, M. B., Ma, M., Goerg, S., Zhou, X., Xia, J., Finco, O., Han, S., Kelsoe, G., Howard, R. G., Rothstein, T. L., Kremmer, E., Rosen, F. S., and Carroll, M. C. (1996) J. Immunol. 157, 549-556
24. Matsumoto, M., Fukuda, W., Circolo, A., Goellner, J., Strauss-Schoenberger, J., Wang, X., Fujita, S., Hidvegi, T., Chaplin, D. D., and Colten, H. R. (1997) Proc. Natl. Acad. Sci. U.S.A. 94, 8720-8725
25. Gros, P., Milder, F. J., and Janssen, B. J. (2008) Nat. Rev. Immunol. 8, 48-58
26. Pangburn, M. K., Schreiber, R. D., and Müller-Eberhard, H. J. (1981) J. Exp. Med. 154, 856-867
27. Andersson, J., Ekdahl, K. N., Larsson, R., Nilsson, U. R., and Nilsson, B. (2002) J. Immunol. 168, 5786-5791
28. Winter, P. M., Schmieder, A. H., Caruthers, S. D., Keene, J. L., Zhang, H., Wickline, S. A., and Lanza, G. M. (2008) Faseb J. 22, 2758-2767
29. Winter, P. M., Caruthers, S. D., Zhang, H., Williams, T. A., Wickline, S. A., and Lanza, G. M. (2008) JACC Cardiovasc. Imaging 1, 624-634
30. Cunningham, C. M., Kingzette, M., Richards, R. L., Alving, C. R., Lint, T. F., and Gewurz, H. (1979) J. Immunol. 122, 1237-1242
31. Chonn, A., Cullis, P. R., and Devine, D. V. (1991) J. Immunol. 146, 4234-4241
32. Kraus, D., Medof, M. E., and Mold, C. (1998) Infect Immun. 66, 399-405
33. Lambris, J. D., Ricklin, D., and Geisbrecht, B. V. (2008) Nat. Rev. Microbiol. 6, 132-142
34. Lundberg, C., Marceau, F., and Hugli, T. E. (1987) Am. J. Pathol. 128, 471-483
35. Niederbichler, A. D., Hoesel, L. M., Westfall, M. V., Gao, H., Ipaktchi, K. R., Sun, L., Zetoune, F. S., Su, G. L., Arbabi, S., Sarma, J. V., Wang, S. C., Hemmila, M. R., and Ward, P. A. (2006) J. Exp. Med. 203, 53-61
36. Ríhová, B. (2002) Adv. Drug Deliv. Rev. 54, 653-674
37. Harris, T. D., and Rajopadhye, M. (January 28, 2003) U. S. Patent 6,511,648